ArticleNature cancer2020
A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response.
Roeland Lameris et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it